CClinicalTrials.gg
CompletedNCT07232394Updated Sep 11, 2026

Early Feeding and Mobilization in Thoracic Surgery

An interventional study of Traditional nursing and ERAS protocol in Thoracic Surgery Lung, Nursing Cares and ERAS, sponsored by Jianxing He. Completed at 1 site in China. Open to participants aged 18 Years to 75 Years. Per ClinicalTrials.gov, last updated 2026-09-11.

Sponsored by Jianxing He · Not applicable, Interventional, and Treatment

From the registry’s dates

  • Registered 10 months after the study started (first participant enrolled Jan 2025, registered Nov 2025).
Phase
Not applicable
Study type
Interventional
Enrollment
300
Allocation
Randomized
Ages
18 Years to 75 Years
Sex
All
01

Study summary

This study evaluates the safety and effectiveness of an innovative care assessment tool for early feeding and mobilization following thoracic surgery, based on the Enhanced Recovery After Surgery (ERAS) protocol. The aim is to improve postoperative recovery by helping healthcare providers implement a structured, evidence-based plan for early feeding and activity. The study will compare the new care model (ERAS-based) with traditional postoperative care. The investigators will focus on outcomes like recovery quality, complications, hospital stay, and medication use. This research aims to provide solid evidence for integrating early feeding and mobilization into routine thoracic surgery recovery, potentially improving patient comfort, reducing recovery time, and lowering complications.

Read the detailed description

Lung cancer remains the leading cause of cancer-related morbidity and mortality worldwide. Surgery, especially for early and intermediate-stage patients, is considered the cornerstone of treatment. With the advancement of minimally invasive techniques, such as video-assisted thoracic surgery (VATS), the degree of surgical trauma and the risk of complications have significantly decreased. However, despite these innovations, postoperative complications still occur in 30%-40% of patients, indicating that improvements in surgical techniques alone are insufficient to eliminate perioperative risks.

In response, the Enhanced Recovery After Surgery (ERAS) protocol has been introduced in thoracic surgery to optimize postoperative recovery. ERAS strategies have shown promising results in reducing complications, pain medication use, and hospital stays. However, most of the clinical evidence supporting ERAS comes from colorectal surgery, with limited research focusing on its application in thoracic surgery. Further validation of its safety, feasibility, and effectiveness in thoracic surgery patients is urgently needed.

One core element of ERAS in thoracic surgery is early postoperative oral feeding. Traditional postoperative management often restricts food and fluids for 4-6 hours to reduce the risk of nausea and vomiting caused by residual anesthesia, but this restriction can lead to discomfort from thirst and hunger. Restoring oral intake as early as possible, provided there is no high aspiration risk and vital signs are stable, has been shown to enhance comfort and recovery. However, clinical implementation of early feeding has been suboptimal, and most related studies have focused on gastrointestinal surgeries. Evidence supporting early feeding in thoracic surgery is still lacking.

In addition to early feeding, early mobilization is another key component of ERAS in thoracic surgery. As the ERAS concept evolves, research has increasingly focused on multi-faceted interventions, suggesting that combining early feeding and mobilization could have a synergistic effect in optimizing postoperative outcomes. Despite this potential, high-quality evidence supporting this combined strategy in thoracic surgery is still limited.

Given these challenges, this study aims to evaluate the safety and effectiveness of a newly developed, time-point-based nursing assessment tool for early feeding and mobilization after thoracic surgery. This single-center, randomized, single-blind, parallel-controlled trial will assess the tool's impact on patient outcomes, including recovery quality, complications, and hospital stay. The ultimate goal is to provide evidence for the clinical adoption and implementation of this tool in thoracic surgery recovery, enhancing patient recovery and contributing to the broader application of ERAS principles in this field.

02

Conditions studied

  • Thoracic Surgery Lung
  • Nursing Cares
  • ERAS

Browse trials for

Keywords

  • ERAS
  • lung cancer
  • video-assisted thoracoscopic surgery
  • nursing care
03

In context

Lung Neoplasms

7,243 studies on the registry are indexed under Lung Neoplasms; 1,557 are open to participants now.

This study's enrollment of 300 is above the median of 60 across 5,295 interventional studies indexed under Lung Neoplasms.

Browse Lung Neoplasms studies →

Lead sponsor

Jianxing He is the lead sponsor of 11 studies on the registry; 6 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 75 Years
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  1. Aged 18 to 75 years, with no gender restrictions;
  2. Planned for elective thoracoscopic surgery, in good physical condition, able to undergo surgery and anesthesia (ASA classification no more than class III), and confirmed suitable for surgery after joint assessment by the medical and nursing team;
  3. No severe cognitive impairment or mental illness, able to cooperate with nursing staff and follow intervention measures;
  4. Normal function of major organs;
  5. The patient has provided informed consent to participate in the study and signed the informed consent form.

Exclusion criteria

Exclusion Criteria:

  1. Patients with cognitive impairment, mental illness, or other conditions that may affect the study;
  2. Requirement to convert to open surgery during the procedure;
  3. Lung cancer with metastasis to other organs;
  4. Failure to sign the informed consent form.
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Single (Participant)
Enrollment
300 participants (actual)

Study arms

  • Experimental
    ERAS nursing group

    The ERAS nursing group implements the Enhanced Recovery After Surgery (ERAS) protocol, where the medical team uses developed assessment tools to individualize the timing for each patient's first mobilization and oral intake after surgery. This intervention aims to promote postoperative recovery, reduce postoperative complications, and shorten hospital stays.

    Behavioral: Traditional nursing · Behavioral: ERAS protocol

  • Active comparator
    Traditional nursing group

    The traditional nursing group receives standard postoperative care, including routine nursing interventions for pain management, mobility, and nutrition.

    Behavioral: Traditional nursing

Interventions

  • BehavioralTraditional nursing

    After the patient is admitted, the nursing team conducts a comprehensive assessment, including blood glucose, blood pressure, medication history, smoking history, alcohol consumption history, etc., to develop the patient's care plan. Preoperatively, the nursing staff will educate the patient about perioperative knowledge and inform the patient about fasting and withholding fluids 8 hours before the surgery. Postoperatively, the nursing staff closely monitors the patient's vital signs, surgical wounds, and drainage, and provides relevant health education. According to medical orders, the nursing team will guide the patient in appropriate eating and activity, and use medications to address postoperative discomfort.

  • BehavioralERAS protocol

    At 0, 2, and 4 hours postoperatively, the nursing team will progressively assess the patient's condition in the order of vital signs, consciousness, nausea and vomiting severity, swallowing function, pain score, and muscle strength. If all the assessment results meet the criteria, the nursing staff will guide the patient to try eating a small amount of liquid food and maintain the head of the bed elevated to a 30-degree angle. At the same time, the nursing staff will guide the patient to follow a progressive activity regimen, starting with sitting up in bed for 3 minutes, then sitting at the bedside for 3 minutes, followed by standing at the bedside for 3 minutes. If there is no discomfort, the patient may walk moderately within the ward.

06

What researchers measure

Primary outcomes

  1. The Quality of Recovery-15 (QoR-15) score

    The QoR-15 scale is a 15-item questionnaire used to assess the patient's quality of life during the postoperative recovery process, covering aspects such as pain, fatigue, anxiety, physical function, and emotional recovery. The higher the total score, the better the postoperative recovery quality.

    Time frame: 24 hours post-surgery.

Secondary outcomes

  1. Chest Tube Placement Duration

    The chest tube placement duration refers to the number of days from the placement of the chest tube after surgery until its removal.

    Time frame: Perioperative.

  2. Total Drainage Volume from Chest Tube

    The total drainage volume from the chest tube refers to the total amount of fluid drained through the chest tube after surgery.

    Time frame: Perioperative.

  3. Postoperative Hospitalization Duration

    The postoperative hospitalization duration refers to the total number of days the patient remains in the hospital from the completion of surgery until discharge.

    Time frame: Perioperative.

  4. Postoperative Complications

    Postoperative complications refer to any adverse events or symptoms that occur after surgery and may affect the patient's recovery.

    Time frame: Perioperative.

  5. Total Hospitalization Costs

    The total cost of hospitalization includes all medical expenses, such as surgical fees, inpatient care, medication costs, and examination fees.

    Time frame: Perioperative.

  6. 30-Day Readmission Rate

    The proportion of patients readmitted to the hospital within 30 days after surgery for any reason.

    Time frame: Within 30 days post-surgery.

  7. 30-Day Mortality Rate

    The mortality rate within 30 days after surgery due to any cause.

    Time frame: Within 30 days post-surgery.

07

Study locations

1 site
  • The First Affiliated Hospital of Guangzhou Medical University
    Guangzhou, Guangdong 510120, China
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 11, 2026, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT07232394
Lead sponsor
Jianxing He
Responsible party
Jianxing He (Professor, The First Affiliated Hospital of Guangzhou Medical University) — Sponsor-investigator
First posted
Nov 18, 2025
Start date
Jan 1, 2025
Primary completion
Jun 1, 2025
Completion
Sep 1, 2025
Last update
Sep 11, 2026

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Sep 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion